LUNSUMIO injection Drug Use Surveillance (Relapsed or Refractory Follicular Lymphoma) (UMIN-CTR) - Oct 25, 2026 - P=N/A | N=120 | Active, not recruiting | Sponsor: Chugai Pharmaceutical Co. Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Oncology
|